Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Investors reacted to Trump's election by pushing up bond yields, equity indices, and the USD, but now face uncertainties ...

BofA has lowered its rating of Hims & Hers (NYSE:HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair ...

(Bloomberg) — Stocks lost traction following a furious post-election rally that spurred calls for a breather amid signs of buyer fatigue. Equities fell from near all-time highs, with the S&P 500 ...

The move places the company in competition with other direct-to-consumer marketplaces including Hims & Hers Health and Ro.

The announcement is Amazon’s most recent move into the pharmacy space Amazon Amazon continued its move into the pharmacy ...

Searle adds that with an improved balance sheet, inorganic growth opportunities, such as mergers and acquisitions, are also becoming a more viable option. For FY24, the analyst projects earnings of 2 ...

Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...

After Amazon (AMZN) announced its launch of its Amazon One Medical Pay-per-visit telehealth service, which is “very similar” to ...